Flu season is in swing and likely won’t let up until April. It seemed like high time to check in on how Americans feel about flu vaccination, so we asked more than 3,000 adults in the latest NPR-Truven Health Analytics Health Poll, conducted during the first half of October.
For people with diabetes, fear can be especially dangerous. Make no mistake, this disease is scary. Both type 1s and type 2s face an array of worrying side effects, both from the condition itself and from the ways we have to treat it.
A new study has shown that adults with diabetic peripheral neuropathy (DPN) are at greater risk of falling during day-to-day activities; this is because they are more likely to have impaired balance.
As of today, 31 Senators (31% of total Senators) and 157 House members (36% of total) have cosponsored the 2015 Medicare CGM Access Act, solid progress since the bill was reintroduced in March. However, over 50% of Congressional and Senate Diabetes Caucus members have yet to co-sponsor the bill.
The International Diabetes Federation released today the 7th Diabetes Atlas, a major research endeavor highlighting the global burden of diabetes. The main takeaways? Globally, 415 million people now have diabetes – that’s one in eleven adults, up from one in 160 (!) in 1985 when only 30 million people globally had diabetes. By 2040, it’s […]
Our team – how lucky we are! – just attended the 2015 Texas FreshAIR biotech conference, where we heard from Google Life Sciences CEO Dr. Andy Conrad on all things Google, including the company’s effort to improve healthcare through new sensors and better data analytics.
In exciting news, the personal genetics company 23andMe announced today the launch of its new “Personal Genome Service,” which has now received formal FDA approval.
In a move sure to befuddle women — and anger some breast cancer survivors — the American Cancer Society has issued new guidelines saying less screening for breast cancer is better than more.
Diabetic macular edema (DME) is a leading source of vision loss around the world, affecting about a fifth of people with long-term diabetes. Drugs that target a protein known as VEGF (vascular endothelial growth factor) inside the eye have greatly improved the treatment options in recent years, but only about half of DME patients are […]
As always, there’s been no shortage of outstanding diabetes blog posts falling from the proverbial tree that is the Diabetes Online Community (DOC). Today, we’re excited to share some that caught our eye during September, along with some posts recommended by DOC peep readers.
Recently, the FDA announced the creation of the first-ever Patient Engagement Advisory Committee (PEAC), designed to advise the agency on medical devices, device regulation, and patient use. Any disease could be covered. The FDA is opening a public comment period for 60 days so people can submit and comment on potential topics for the advisory […]
Last year’s flu vaccine didn’t work very well. This year’s version should do a much better job protecting people against the flu, federal health officials said Thursday. An analysis of the most common strains of flu virus that are circulating in the United States and elsewhere found they match the strains included in this year’s […]
Whether you’re newly diagnosed or an insulin veteran, staying up-to-date on the latest diabetes news as well as seeking support from others is a great way to help yourself. Keep reading to learn more about this year’s best Twitter accounts for diabetes.
More than half of Asian Americans with diabetes don’t know they have the condition, according to new research that quantifies, for the first time, how common diabetes is among that minority group in the United States.
After diabetes diagnosis, many type 1 and type 2 diabetics worry about their life expectancy. Death is never a pleasant subject but it’s human nature to want to know ‘how long can I expect to live’. There is no hard and fast answer to the question of ‘how long can I expect to live’ as […]
GOOGLE’S LIFE SCIENCES division has its first big mission: developing new ways to treat and manage diabetes. But in a sign that the company is serious about making real progress, it’s not diving into diabetes research alone. It is working with French pharmaceutical giant Sanofi, one of the world’s largest pharmaceutical companies.
Since I started my practice as an endocrinologist, I’ve had tens of thousands of office visits, mainly seeing people with diabetes. Here’s my wish list of some of the things people with diabetes should know, and do, to succeed. My “best” patients may not be the ones who do every single one of these, but […]
The little pink pill, known generically as flibanserin, will be sold under the brand name Addyi beginning Oct. 17, according to its maker, Sprout Pharmaceuticals. The medicine is to be taken daily to treat premenopausal women suffering from hypoactive sexual desire disorder, which is essentially a sudden, unexplained loss of any desire to have sex.
Too many older Americans are falling short when it comes to their diabetes care, according to a new study.
A study from the University of Alabama at Birmingham (UAB) is testing a drug to stop the body from destroying beta cells at the onset of Type 1 diabetes, and they are casting a wide net to find volunteers, according to a WIAT.com article.